Synthesis, characterization and toxicity profiling of graphene oxide-metformin hydrogel as a sustained release system for metformin in-vitro
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Materials Today: Proceedings
- Vol. 36, 769-774
Abstract
No abstract availableKeywords
Funding Information
- National Agri-Food Biotechnology Institute
This publication has 21 references indexed in Scilit:
- Antidiabetic activity enhancement in streptozotocin + nicotinamide–induced diabetic rats through combinational polymeric nanoformulationInternational Journal of Nanomedicine, 2019
- The mechanisms of action of metforminDiabetologia, 2017
- Evaluation of anti-diabetic activity of glycyrrhizin-loaded nanoparticles in nicotinamide-streptozotocin-induced diabetic ratsEuropean Journal of Pharmaceutical Sciences, 2017
- A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?Pharmacological Research, 2017
- Metformin-loaded alginate nanoparticles as an effective antidiabetic agent for controlled drug releaseJournal of Pharmacy and Pharmacology, 2016
- Designing hydrogels for controlled drug deliveryNature Reviews Materials, 2016
- Biomedical Applications of Graphene and Graphene OxideAccounts of Chemical Research, 2013
- Metformin: an old but still the best treatment for type 2 diabetesDiabetology & Metabolic Syndrome, 2013
- Clinical Pharmacokinetics of MetforminClinical Pharmacokinetics, 2011
- Mechanism by which metformin reduces glucose production in type 2 diabetes.Diabetes, 2000